AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BIOTECH

Net Asset Value Mar 14, 2016

9301_rns_2016-03-14_3ead0f91-e989-4f76-812a-c039a4cd2392.html

Net Asset Value

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

THE BIOTECH GROWTH TRUST PLC - Transaction in Own Shares

PR Newswire

London, March 11

                                                      For immediate release                                                                  11 March 2016                         THE BIOTECH GROWTH TRUST PLC                                (the "Company")                    MARKET PURCHASE OF COMPANY'S OWN SHARESNotification is given, pursuant to the authority granted at the Annual GeneralMeeting of the Company held 8 July 2015 to make market purchases of theCompany's own shares up to an aggregate maximum of 9,380,031 that a markettotal of 41,001 Ordinary shares of 25p each in the capital of the Company werepurchased on Friday, 11 March 2016 for cancellation by the Company at a priceof 579.31 pence per share.Following this transaction and in conformity with the provisions of theTransparency Directive, the Company hereby notifies the market that; the totalnumber of Ordinary shares that the Company has in issue, less the total numberof Ordinary shares bought back for cancellation by the Company following suchpurchase, and therefore, the total number of voting rights in the Company is60,351,754. The Company does not currently hold any Ordinary shares intreasury.The figure of 60,351,754 may be used by shareholders as the denominator for thecalculation by which they may determine if they are required to notify theirinterest in, or change to their interest in, the Company under the FCA'sDisclosure and Transparency Rules.For and on behalf ofFrostrow Capital LLPCompany SecretaryFor further information, please contact:Mark PopeFrostrow Capital LLPTel: 020 3 170 4913END

Talk to a Data Expert

Have a question? We'll get back to you promptly.